A detailed history of Bank Plus Trust Department transactions in Abbott Laboratories stock. As of the latest transaction made, Bank Plus Trust Department holds 25,429 shares of ABT stock, worth $3.14 Million. This represents 0.91% of its overall portfolio holdings.

Number of Shares
25,429
Previous 24,517 3.72%
Holding current value
$3.14 Million
Previous $3.33 Billion 2.14%
% of portfolio
0.91%
Previous 0.99%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 17, 2025

BUY
$120.51 - $136.62 $109,905 - $124,597
912 Added 3.72%
25,429 $3.41 Billion
Q2 2025

Jul 23, 2025

BUY
$123.95 - $138.08 $261,162 - $290,934
2,107 Added 9.4%
24,517 $3.33 Billion
Q1 2025

May 01, 2025

BUY
$111.1 - $140.22 $217,311 - $274,270
1,956 Added 9.56%
22,410 $2.97 Billion
Q4 2024

Feb 04, 2025

BUY
$111.93 - $119.39 $2.29 Million - $2.44 Million
20,454 New
20,454 $2.31 Billion

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $216B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Bank Plus Trust Department Portfolio

Follow Bank Plus Trust Department and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Plus Trust Department, based on Form 13F filings with the SEC.

News

Stay updated on Bank Plus Trust Department with notifications on news.